Model development and validation for predicting small-cell lung cancer bone metastasis utilizing diverse machine learning algorithms based on the SEER database

被引:0
作者
Qie, Shuai [1 ]
Zhang, Xin [1 ]
Luan, Jiusong [1 ]
Song, Zhelun [1 ]
Li, Jingyun [1 ]
Wang, Jingyu [1 ]
机构
[1] Hebei Univ, Affiliated Hosp, Dept Radiat Oncol, Baoding 071000, Hebei, Peoples R China
关键词
bone metastasis; machine learning; prognosis; SEER; small-cell lung cancer; PROGNOSTIC-FACTORS; STAGE;
D O I
10.1097/MD.0000000000041987
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of this study was to devise a machine learning algorithm with superior performance in predicting bone metastasis (BM) in small cell lung cancer (SCLC) and create a straightforward web-based predictor based on the developed algorithm. Data comprising demographic and clinicopathological characteristics of patients with SCLC and their potential BM were extracted from the Surveillance, Epidemiology, and End Results database between 2010 and 2018. This data was then utilized to develop 12 machine learning algorithm models: support vector machine, logistic regression, NaiveBayes, extreme gradient boosting, decision tree, random forest, ExtraTrees, LightGBM, GradientBoosting, AdaBoost, MLP, and k-nearest neighbor. The models were compared and evaluated using various metrics, including accuracy, precision, recall rate, F1-score, the area under the receiver operating characteristic curve (AUC) value, and the Brier score. The objective was to predict the likelihood of BM in SCLC patients based on their demographic and clinicopathological features. The best-performing model was then chosen, and the associations between the clinicopathological characteristics and the target variable (presence or absence of BM) were interpreted based on this model. This analysis aimed to provide insights into the factors that may influence the risk of BM in SCLC patients. A total of 89,366 SCLC patients were included in this study, and among them, 8269 (9.25%) patients developed BM. The age, T stage, N stage, liver metastasis, lung metastasis, marital status, income, M stage, American Joint Committee on Cancer stage, and brain metastasis were identified as independent risk factors for SCLC. Among the various predictive models evaluated, the machine learning model utilizing the XGB algorithm showed the highest performance in both internal and external data validation, achieving AUC scores of training set AUC: 0.965, validation set AUC: 0.962, and testing set AUC: 0.961. Subsequently, the XGB algorithm was utilized to develop a web-based predictor for BM in patients with SCLC. This study has developed a web-based predictor utilizing the XGB algorithm to forecast the risk of BM in SCLC patients, aiming to provide doctors with valuable assistance in clinical decision-making.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] The Construction and Validation of a new Predictive Model for Overall Survival of Clear Cell Renal Cell Carcinoma Patients with Bone Metastasis Based on Machine Learning Algorithm
    Le, Yijun
    Xu, Wen
    Guo, Wei
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2023, 22
  • [42] MGr1-Ag promotes invasion and bone metastasis of small-cell lung cancer in vitro and in vivo
    Zhang, Feng
    Wang, Yanxia
    Xu, Min
    Dong, Haiying
    Liu, Na
    Zhou, Jing
    Pang, Hailin
    Ma, Ningqiang
    Zhang, Ning
    Pei, Yanlin
    Zhang, Helong
    Liu, Lili
    ONCOLOGY REPORTS, 2013, 29 (06) : 2283 - 2290
  • [43] Predictors for survival in patients with bone metastasis of small cell lung cancer A population-based study
    Xue, MingFeng
    Chen, Gang
    Chen, XingGuang
    Hu, JunYu
    MEDICINE, 2021, 100 (34) : E27070
  • [44] Development and validation of nomograms based on the SEER database for the risk factors and prognosis of distant metastasis in gastric signet ring cell carcinoma
    Shi, Haomin
    Yang, Huilian
    Yan, Su
    Zhang, Qi
    Wang, Xingbin
    MEDICINE, 2024, 103 (44) : e40382
  • [45] A clinical prediction model for predicting the risk of liver metastasis from renal cell carcinoma based on machine learning
    Wang, Ziye
    Xu, Chan
    Liu, Wencai
    Zhang, Meiying
    Zou, Jian'an
    Shao, Mingfeng
    Feng, Xiaowei
    Yang, Qinwen
    Li, Wenle
    Shi, Xiue
    Zang, Guangxi
    Yin, Chengliang
    FRONTIERS IN ENDOCRINOLOGY, 2023, 13
  • [46] Development and validation of a nomogram for predicting overall survival in patients with stage III-N2 lung adenocarcinoma based on the SEER database
    Zhang, Shengchao
    Xiao, Xiangzhi
    Qin, Xuan
    Xia, Hongwei
    TRANSLATIONAL CANCER RESEARCH, 2023, 12 (10) : 2742 - 2753
  • [47] Machine learning-based prediction model for brain metastasis in patients with extensive-stage small cell lung cancer
    Munai, Erha
    Zeng, Siwei
    Yuan, Ze
    Yang, Dingyi
    Jiang, Yong
    Wang, Qiang
    Wu, Yongzhong
    Zhang, Yunyun
    Tao, Dan
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [48] Development and validation of an interpretable machine learning model for predicting the risk of distant metastasis in papillary thyroid cancer: a multicenter study
    Hou, Fei
    Zhu, Yun
    Zhao, Hongbo
    Cai, Haolin
    Wang, Yinghui
    Peng, Xiaoqi
    Lu, Lin
    He, Rongli
    Hou, Yan
    Li, Zhenhui
    Chen, Ting
    ECLINICALMEDICINE, 2024, 77
  • [49] Development and Validation of a Deep Learning Model for Non-Small Cell Lung Cancer Survival
    She, Yunlang
    Jin, Zhuochen
    Wu, Junqi
    Deng, Jiajun
    Zhang, Lei
    Su, Hang
    Jiang, Gening
    Liu, Haipeng
    Xie, Dong
    Cao, Nan
    Ren, Yijiu
    Chen, Chang
    JAMA NETWORK OPEN, 2020, 3 (06)
  • [50] Identification of key gene signatures for predicting chemo-immunotherapy efficacy in extensive-stage small-cell lung cancer using machine learning
    Fujimoto, Daichi
    Shibaki, Ryota
    Kimura, Keiichi
    Haratani, Koji
    Tamiya, Motohiro
    Kijima, Takashi
    Sato, Yuki
    Hata, Akito
    Yokoyama, Toshihide
    Taniguchi, Yoshihiko
    Uchida, Junji
    Tanaka, Hisashi
    Furuya, Naoki
    Miura, Satoru
    Onishi, Mihoko Imaji
    Sakata, Shinya
    Miyauchi, Eisaku
    Yamamoto, Nobuyuki
    Koh, Yasuhiro
    Akamatsu, Hiroaki
    LUNG CANCER, 2025, 199